2487 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Cutia Therapeutics is a holding company, which engages in the research and development of dermatology treatment solutions and products through its subsidiaries. Its product portfolios include scalp diseases and care, skin diseases and care, localized adipose accumulation management medication, and topical anesthesia. The company was founded by Le Le Zhang on May 15, 2019 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
2487 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company